CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Novo Holdings A/s sold $8.2M of Corvus Pharmaceuticals, Inc.
10% owner
Sold$8,168,547
$5.31Price
1,538,062Shares
−53%Stake
What CRVS did after the filing
Prices for CRVS after this filing aren't in yet.
Traded Tue, Jul 7. Filed Thu, Jul 9, 4:35 PM ET, after the close. Not investment advice.